Mauricio Pimentel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mauricio Pimentel has a total of 226 co-authors. Here are the top co-authors by number of shared publications:
- Leandro Ioschpe Zimerman
Hospital de Clínicas de Porto Alegre
13 shared publications - Lucas Simonetto Faganello
Hospital de Clínicas de Porto Alegre
9 shared publications - Anderson Donelli da Silveira
Hospital de Clinicas de Porto Alegre, Brasil; Programa de Pós-Graduação em Cardiologia Universidade Federal do Rio Grande do Sul, Brasil; Hospital Moinhos de Vento, Brasil
7 shared publications - Cristiano Faria Pisani
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brasil
7 shared publications - Luciana Sacilotto
Universidade de São Paulo
7 shared publications Ana Paula Arbo Magalhães
Hospital de Clínicas de Porto Alegre
5 shared publications
Latest Publications
- 28 October 2026
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 39
Prognostic Value of QTc Interval and Other Ventricular Repolarization Parameters in Acute Stroke
Background: The electrocardiogram (ECG) is routinely used in stroke evaluation, although interactions within the brain–heart axis remain incompletely understood. The prognostic relevance of the QTc interval and other ventricular repolarization markers has gained increasing interest in stroke populations. Objectives: To evaluate the association of QTc interval, QTc dispersion (QTc-d), Tpeak–end interval (Tp-e), and Tp-e/QTc ratio with neurological disability and in-hospital mortality in acute stroke. Methods: This retrospective cohort included patients admitted with acute stroke between January 2018 and April [...] Abstract Background: The electrocardiogram (ECG) is routinely used in stroke evaluation, although interactions within the brain–heart axis remain incompletely understood. The prognostic relevance of the QTc interval and other ventricular repolarization markers has gained increasing interest in stroke populations. Objectives: To evaluate the association of QTc interval, QTc dispersion (QTc-d), Tpeak–end interval (Tp-e), and Tp-e/QTc ratio with neurological disability and in-hospital mortality in acute stroke. Methods: This retrospective cohort included patients admitted with acute stroke between January 2018 and April
- 28 October 2026
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 39
Prognostic Value of QTc Interval and Other Ventricular Repolarization Parameters in Acute Stroke
Background: The electrocardiogram (ECG) is routinely used in stroke evaluation, although interactions within the brain–heart axis remain incompletely understood. The prognostic relevance of the QTc interval and other ventricular repolarization markers has gained increasing interest in stroke populations. Objectives: To evaluate the association of QTc interval, QTc dispersion (QTc-d), Tpeak–end interval (Tp-e), and Tp-e/QTc ratio with neurological disability and in-hospital mortality in acute stroke. Methods: This retrospective cohort included patients admitted with acute stroke between January 2018 and April [...] Abstract Background: The electrocardiogram (ECG) is routinely used in stroke evaluation, although interactions within the brain–heart axis remain incompletely understood. The prognostic relevance of the QTc interval and other ventricular repolarization markers has gained increasing interest in stroke populations. Objectives: To evaluate the association of QTc interval, QTc dispersion (QTc-d), Tpeak–end interval (Tp-e), and Tp-e/QTc ratio with neurological disability and in-hospital mortality in acute stroke. Methods: This retrospective cohort included patients admitted with acute stroke between January 2018 and April
- Open Access
- 28 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Síndrome de Wolff–Parkinson–White em uma Receptora de Transplante Cardíaco
Uma mulher de 44 anos foi submetida a transplante cardíaco devido a angina refratária e insuficiência cardíaca avançada. No período pós-operatório, apresentou episódios de taquicardia supraventricular e pré-excitação ventricular intermitente no eletrocardiograma. Após um período inicial de manejo farmacológico, foi submetida com sucesso à ablação por radiofrequência de uma via acessória póstero-septal esquerda. Também é apresentada uma revisão da literatura sobre a síndrome de Wolff–Parkinson–White em receptores de transplante cardíaco.
- 28 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Open AccessSíndrome de Wolff–Parkinson–White em uma Receptora de Transplante Cardíaco
Uma mulher de 44 anos foi submetida a transplante cardíaco devido a angina refratária e insuficiência cardíaca avançada. No período pós-operatório, apresentou episódios de taquicardia supraventricular e pré-excitação ventricular intermitente no eletrocardiograma. Após um período inicial de manejo farmacológico, foi submetida com sucesso à ablação por radiofrequência de uma via acessória póstero-septal esquerda. Também é apresentada uma revisão da literatura sobre a síndrome de Wolff–Parkinson–White em receptores de transplante cardíaco.
- Open Access
- 28 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Wolff–Parkinson–White Syndrome in a Heart Transplant Recipient
A 44-year-old woman underwent heart transplantation due to refractory angina and advanced heart failure. During the postoperative period, she developed episodes of supraventricular tachycardia and intermittent ventricular pre-excitation on the electrocardiogram. After an initial period of pharmacological management, she underwent successful radiofrequency ablation of a left posteroseptal accessory pathway. A review of the literature regarding Wolff–Parkinson–White syndrome in heart transplant recipients is also presented. Wolff–Parkinson–White Syndrome in a Heart Transplant Recipient Abstract A 44-year-old woman underwent heart transplantation due to refractory angina and advanced heart failure. During the postoperative period, she developed episodes of supraventricular tachycardia and intermittent ventricular pre-excitation on the electrocardiogram. After an initial period of pharmacological management, she underwent successful radiofrequency ablation of a left posteroseptal accessory pathway. A review of the literature regarding Wolff–Parkinson–White syndrome in heart transplant recipients is also presented. Wolff–Parkinson–White Syndrome in a Heart Transplant Recipient
- 28 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Open AccessWolff–Parkinson–White Syndrome in a Heart Transplant Recipient
A 44-year-old woman underwent heart transplantation due to refractory angina and advanced heart failure. During the postoperative period, she developed episodes of supraventricular tachycardia and intermittent ventricular pre-excitation on the electrocardiogram. After an initial period of pharmacological management, she underwent successful radiofrequency ablation of a left posteroseptal accessory pathway. A review of the literature regarding Wolff–Parkinson–White syndrome in heart transplant recipients is also presented. Wolff–Parkinson–White Syndrome in a Heart Transplant Recipient Abstract A 44-year-old woman underwent heart transplantation due to refractory angina and advanced heart failure. During the postoperative period, she developed episodes of supraventricular tachycardia and intermittent ventricular pre-excitation on the electrocardiogram. After an initial period of pharmacological management, she underwent successful radiofrequency ablation of a left posteroseptal accessory pathway. A review of the literature regarding Wolff–Parkinson–White syndrome in heart transplant recipients is also presented. Wolff–Parkinson–White Syndrome in a Heart Transplant Recipient
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (8)
Systematic Review on the Safety of Physical Exercise in Hypertrophic Cardiomyopathy: Recommendations from the Brazilian Society of Cardiology
Background Although historically discouraged due to the risk of arrhythmias and sudden cardiac death (SCD), physical exercise (PE) may be safe and beneficial for individuals with hypertrophic cardiomyopathy (HCM). Objective To evaluate the association between PE and the incidence of mortality and arrhythmic events in adults with HCM, stratifying the analysis according to different types and intensities of exercise. Methods Systematic review of randomized clinical trials (RCTs) and observational studies identified in PubMed, Embase, and the Cochrane Library through December 2024. Studies including individuals exposed to different intensities of PE were eligible. Risk of bias was assessed using the RoB 2 and ROBINS-I tools, and certainty of evidence using GRADE. Recommendations were developed by an expert panel of the Brazilian Society of Cardiology. Results Eight studies (four RCTs and four observational studies; 9,744 participants) were included. None reported an increased risk of mortality or severe arrhythmic events associated with PE, even at moderate or vigorous intensities. Syncope was rare. Additionally, a Korean observational study involving more than 7,000 participants (mean age: 59 years) demonstrated reduced all-cause mortality with higher physical activity intensity (dose–response curve). In low-risk athletes, competitive sports were not associated with severe adverse events. The quality of evidence ranged from moderate to very low. Conclusion PE in HCM should be encouraged based on individualized assessment. In patients without high-risk criteria for SCD, benefits appear to outweigh risks. For higher-risk subgroups, recommendations are more cautious and based on expert consensus.
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (8)
Open AccessSystematic Review on the Safety of Physical Exercise in Hypertrophic Cardiomyopathy: Recommendations from the Brazilian Society of Cardiology
Background Although historically discouraged due to the risk of arrhythmias and sudden cardiac death (SCD), physical exercise (PE) may be safe and beneficial for individuals with hypertrophic cardiomyopathy (HCM). Objective To evaluate the association between PE and the incidence of mortality and arrhythmic events in adults with HCM, stratifying the analysis according to different types and intensities of exercise. Methods Systematic review of randomized clinical trials (RCTs) and observational studies identified in PubMed, Embase, and the Cochrane Library through December 2024. Studies including individuals exposed to different intensities of PE were eligible. Risk of bias was assessed using the RoB 2 and ROBINS-I tools, and certainty of evidence using GRADE. Recommendations were developed by an expert panel of the Brazilian Society of Cardiology. Results Eight studies (four RCTs and four observational studies; 9,744 participants) were included. None reported an increased risk of mortality or severe arrhythmic events associated with PE, even at moderate or vigorous intensities. Syncope was rare. Additionally, a Korean observational study involving more than 7,000 participants (mean age: 59 years) demonstrated reduced all-cause mortality with higher physical activity intensity (dose–response curve). In low-risk athletes, competitive sports were not associated with severe adverse events. The quality of evidence ranged from moderate to very low. Conclusion PE in HCM should be encouraged based on individualized assessment. In patients without high-risk criteria for SCD, benefits appear to outweigh risks. For higher-risk subgroups, recommendations are more cautious and based on expert consensus.
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (8)
Revisão Sistemática sobre a Segurança do Exercício Físico na Cardiomiopatia Hipertrófica: Recomendações da Sociedade Brasileira de Cardiologia
Resumo Fundamento Embora historicamente desaconselhado devido ao risco de arritmias e morte súbita cardíaca (MSC), o exercício físico (EF) pode ser seguro e benéfico para indivíduos com cardiomiopatia hipertrófica (CMH). Objetivo Avaliar a associação entre a prática de EF e a incidência de mortalidade e de eventos arrítmicos em adultos portadores de CMH, estratificando a análise conforme os diferentes tipos e intensidades de exercício realizados. Métodos Revisão sistemática de ensaios clínicos randomizados (ECRs) e estudos observacionais identificados nas bases de dados PubMed, Embase e Cochrane Library até dezembro de 2024. Foram incluídos estudos com indivíduos submetidos a diferentes intensidades de EF. O risco de viés foi avaliado pelas ferramentas RoB 2 e ROBINS-I, e a certeza da evidência, pela ferramenta GRADE. As recomendações foram elaboradas por um painel de especialistas da Sociedade Brasileira de Cardiologia. Resultados Oito estudos (quatro ECRs e quatro observacionais; 9744 participantes) foram incluídos. Nenhum deles relatou aumento no risco de mortalidade ou de eventos arrítmicos graves associados ao EF, mesmo em intensidades moderadas ou vigorosas. A ocorrência de síncope foi rara. Além disso, um estudo observacional coreano, envolvendo mais de 7 mil participantes (idade média: 59 anos), demonstrou redução da mortalidade por todas as causas com maior intensidade de atividade física (curva dose-resposta). Em atletas de baixo risco, o esporte competitivo não se associou a eventos adversos graves. A qualidade da evidência variou de moderada a muito baixa. Conclusão O EF na CMH deve ser incentivado com base em avaliação individualizada. Em pacientes sem critérios para alto risco de MSC, os benefícios parecem superar os riscos. Para subgrupos de maior risco, a recomendação é mais cautelosa e baseada em consenso de especialistas.
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (8)
Open AccessRevisão Sistemática sobre a Segurança do Exercício Físico na Cardiomiopatia Hipertrófica: Recomendações da Sociedade Brasileira de Cardiologia
Resumo Fundamento Embora historicamente desaconselhado devido ao risco de arritmias e morte súbita cardíaca (MSC), o exercício físico (EF) pode ser seguro e benéfico para indivíduos com cardiomiopatia hipertrófica (CMH). Objetivo Avaliar a associação entre a prática de EF e a incidência de mortalidade e de eventos arrítmicos em adultos portadores de CMH, estratificando a análise conforme os diferentes tipos e intensidades de exercício realizados. Métodos Revisão sistemática de ensaios clínicos randomizados (ECRs) e estudos observacionais identificados nas bases de dados PubMed, Embase e Cochrane Library até dezembro de 2024. Foram incluídos estudos com indivíduos submetidos a diferentes intensidades de EF. O risco de viés foi avaliado pelas ferramentas RoB 2 e ROBINS-I, e a certeza da evidência, pela ferramenta GRADE. As recomendações foram elaboradas por um painel de especialistas da Sociedade Brasileira de Cardiologia. Resultados Oito estudos (quatro ECRs e quatro observacionais; 9744 participantes) foram incluídos. Nenhum deles relatou aumento no risco de mortalidade ou de eventos arrítmicos graves associados ao EF, mesmo em intensidades moderadas ou vigorosas. A ocorrência de síncope foi rara. Além disso, um estudo observacional coreano, envolvendo mais de 7 mil participantes (idade média: 59 anos), demonstrou redução da mortalidade por todas as causas com maior intensidade de atividade física (curva dose-resposta). Em atletas de baixo risco, o esporte competitivo não se associou a eventos adversos graves. A qualidade da evidência variou de moderada a muito baixa. Conclusão O EF na CMH deve ser incentivado com base em avaliação individualizada. Em pacientes sem critérios para alto risco de MSC, os benefícios parecem superar os riscos. Para subgrupos de maior risco, a recomendação é mais cautelosa e baseada em consenso de especialistas.
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Position Statement on the Diagnosis and Treatment of Electrical Storm – 2026
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Open AccessPosition Statement on the Diagnosis and Treatment of Electrical Storm – 2026
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4) , e20260215
Posicionamento sobre Diagnóstico e Tratamento da Tempestade Elétrica – 2026
Sumário […] Posicionamento sobre Diagnóstico e Tratamento da Tempestade Elétrica – 2026 Sumário […] Posicionamento sobre Diagnóstico e Tratamento da Tempestade Elétrica – 2026
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4) , e20260215
Open AccessPosicionamento sobre Diagnóstico e Tratamento da Tempestade Elétrica – 2026
Sumário […] Posicionamento sobre Diagnóstico e Tratamento da Tempestade Elétrica – 2026 Sumário […] Posicionamento sobre Diagnóstico e Tratamento da Tempestade Elétrica – 2026
- Open Access
- 31 December 2025
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 5 (4)
Taquicardia Supraventricular Recorrente em Paciente com Coração Transplantado
- 31 December 2025
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 5 (4)
Open AccessTaquicardia Supraventricular Recorrente em Paciente com Coração Transplantado
- 31 December 2025
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 5 (4)
Recurrent Supraventricular Tachycardia in a Patient with Heart Transplant
- 31 December 2025
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 5 (4)
Recurrent Supraventricular Tachycardia in a Patient with Heart Transplant
- Open Access
- 14 October 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
Brazilian Atrial Fibrillation Guidelines – 2025
- 14 October 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
Open AccessBrazilian Atrial Fibrillation Guidelines – 2025